Support guide for symptom assessment in patients with myeloproliferative syndromes using the mpn-10 scale

Detalhes bibliográficos
Autor(a) principal: Rocha, Andreia
Data de Publicação: 2018
Outros Autores: Ricou , Cláudia, Pereira, Elisabete, Valério , Elisabete, Sanchez, Júan, Jorge Freitas, M., Caeiro, Márcia, Sarmento , Maria, Duarte, Marta, Ponte , Sandra, Frias, Sónia
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://onco.news/index.php/journal/article/view/77
Resumo: Myeloproliferative neoplasms (PH-) – Myelofibrosis, Polycythemia Vera and Essential Thrombocythemia – represents a heterogeneous disorders of the hematopoietic system associated with debilitating symptoms with consequent reduction of the quality of life and negative impact on the daily activities of of patients. The National Comprehensive Cancer Network (NCCN) guidelines, based on the Myeloproliferative Neoplasm Symptom Assessment Form, Total Symptom Score (MPN-SAF TSS) tool, were initiated by some Portuguese hospitals and began monitoring and, systematically, evaluating the symptoms of these patients. This tool, validated for the Portuguese language, has been applied with the support of the nursing teams. In Nurses Focus Group model they discuss the main challenges in using the MPN-10 assessment tool, following which the present guide was developed. The most relevant aspects of the application of this tool were identified: 1) to take into account that it is a self-completion scale; 2) the tool aims to assess the impact of the symptom using numerical categories and 3) the healthcare professionals should not refer / induce the patient for comparison with previous evaluations. To facilitate the understanding of the MPN-10 and methodology of filling by the patient, additional information was developed on each of the symptoms for use by the health professional at the moment of information/clarification to the patient.
id RCAP_2711360d4d73d117c257764f6e7b6f7b
oai_identifier_str oai:oai.onco.news:article/77
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Support guide for symptom assessment in patients with myeloproliferative syndromes using the mpn-10 scaleGuia de apoio para avaliação de sintomalogia em doentes com síndromes mieloproliferativos através da aplicação da escala mpn-10Neoplasias MieloproliferativasSintomasMPN-10Myeloproliferative neoplasmsSymptomsMPN-10Myeloproliferative neoplasms (PH-) – Myelofibrosis, Polycythemia Vera and Essential Thrombocythemia – represents a heterogeneous disorders of the hematopoietic system associated with debilitating symptoms with consequent reduction of the quality of life and negative impact on the daily activities of of patients. The National Comprehensive Cancer Network (NCCN) guidelines, based on the Myeloproliferative Neoplasm Symptom Assessment Form, Total Symptom Score (MPN-SAF TSS) tool, were initiated by some Portuguese hospitals and began monitoring and, systematically, evaluating the symptoms of these patients. This tool, validated for the Portuguese language, has been applied with the support of the nursing teams. In Nurses Focus Group model they discuss the main challenges in using the MPN-10 assessment tool, following which the present guide was developed. The most relevant aspects of the application of this tool were identified: 1) to take into account that it is a self-completion scale; 2) the tool aims to assess the impact of the symptom using numerical categories and 3) the healthcare professionals should not refer / induce the patient for comparison with previous evaluations. To facilitate the understanding of the MPN-10 and methodology of filling by the patient, additional information was developed on each of the symptoms for use by the health professional at the moment of information/clarification to the patient.As neoplasias mieloproliferativas cromossoma Filadélfia negativo (PH-), em particular a Mielofibrose, Policitemia Vera e Trombocitemia Essencial, representam um grupo heterogéneo de distúrbios do sistema hematopoiético associado a sintomas debilitantes com consequente redução da qualidade de vida e impacto negativo nas atividades de vida diária dos doentes. Focados nestes aspectos, algumas unidades hospitalares portuguesas iniciaram a monitorização e avaliação sistemática dos sintomas destes doentes tomando por base a escala Myeloproliferative Neoplasm Symptom Assessment Form, Total Symptom Score (MPN-SAF TSS), conforme recomendado pelas guidelines da National Comprehensive Cancer Network (NCCN). A escala, validada para a língua portuguesa, tem sido aplicada com o apoio das equipas de enfermagem destes centros. Os profissionais de saúde envolvidos estiveram reunidos, em modelo de Focus Group, para debater os principais desafios inerentes à utilização da escala MPN-10, na sequência do qual foi desenvolvido o presente guia. Foram identificados como aspetos mais relevantes na aplicação da escala: 1) ter em consideração que se trata de uma escala de auto-preenchimento; 2) a escala visa a avaliação do impacto do sintoma recorrendo a categorias numéricas e, 3) o profissional não deve remeter / induzir o doente para comparação com avaliações anteriores. Para facilitar a compreensão da escala e metodologia de preenchimento pelo doente foi desenvolvida informação adicional sobre cada um dos sintomas para utilização pelo profissional de saúde no momento de informação / esclarecimentos ao doente.AEOP – Associação de Enfermagem Oncológica Portuguesa2018-06-20info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://onco.news/index.php/journal/article/view/77Onco.news; No. 36 (2018): Onco.News Journal (january-june); 41-44Onco.News; N.º 36 (2018): Revista Onco.News (janeiro-junho); 41-442183-69141646-7868reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://onco.news/index.php/journal/article/view/77https://onco.news/index.php/journal/article/view/77/93Direitos de Autor (c) 2018 Andreia Rocha, Cláudia Ricou , Elisabete Pereira, Elisabete Valério , Júan Sanchez, M. Jorge Freitas, Márcia Caeiro, Maria Sarmento , Marta Duarte, Sandra Ponte , Sónia Friasinfo:eu-repo/semantics/openAccessRocha, AndreiaRicou , CláudiaPereira, ElisabeteValério , ElisabeteSanchez, JúanJorge Freitas, M.Caeiro, MárciaSarmento , MariaDuarte, MartaPonte , SandraFrias, Sónia2024-03-16T07:55:16Zoai:oai.onco.news:article/77Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T04:01:21.061662Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Support guide for symptom assessment in patients with myeloproliferative syndromes using the mpn-10 scale
Guia de apoio para avaliação de sintomalogia em doentes com síndromes mieloproliferativos através da aplicação da escala mpn-10
title Support guide for symptom assessment in patients with myeloproliferative syndromes using the mpn-10 scale
spellingShingle Support guide for symptom assessment in patients with myeloproliferative syndromes using the mpn-10 scale
Rocha, Andreia
Neoplasias Mieloproliferativas
Sintomas
MPN-10
Myeloproliferative neoplasms
Symptoms
MPN-10
title_short Support guide for symptom assessment in patients with myeloproliferative syndromes using the mpn-10 scale
title_full Support guide for symptom assessment in patients with myeloproliferative syndromes using the mpn-10 scale
title_fullStr Support guide for symptom assessment in patients with myeloproliferative syndromes using the mpn-10 scale
title_full_unstemmed Support guide for symptom assessment in patients with myeloproliferative syndromes using the mpn-10 scale
title_sort Support guide for symptom assessment in patients with myeloproliferative syndromes using the mpn-10 scale
author Rocha, Andreia
author_facet Rocha, Andreia
Ricou , Cláudia
Pereira, Elisabete
Valério , Elisabete
Sanchez, Júan
Jorge Freitas, M.
Caeiro, Márcia
Sarmento , Maria
Duarte, Marta
Ponte , Sandra
Frias, Sónia
author_role author
author2 Ricou , Cláudia
Pereira, Elisabete
Valério , Elisabete
Sanchez, Júan
Jorge Freitas, M.
Caeiro, Márcia
Sarmento , Maria
Duarte, Marta
Ponte , Sandra
Frias, Sónia
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Rocha, Andreia
Ricou , Cláudia
Pereira, Elisabete
Valério , Elisabete
Sanchez, Júan
Jorge Freitas, M.
Caeiro, Márcia
Sarmento , Maria
Duarte, Marta
Ponte , Sandra
Frias, Sónia
dc.subject.por.fl_str_mv Neoplasias Mieloproliferativas
Sintomas
MPN-10
Myeloproliferative neoplasms
Symptoms
MPN-10
topic Neoplasias Mieloproliferativas
Sintomas
MPN-10
Myeloproliferative neoplasms
Symptoms
MPN-10
description Myeloproliferative neoplasms (PH-) – Myelofibrosis, Polycythemia Vera and Essential Thrombocythemia – represents a heterogeneous disorders of the hematopoietic system associated with debilitating symptoms with consequent reduction of the quality of life and negative impact on the daily activities of of patients. The National Comprehensive Cancer Network (NCCN) guidelines, based on the Myeloproliferative Neoplasm Symptom Assessment Form, Total Symptom Score (MPN-SAF TSS) tool, were initiated by some Portuguese hospitals and began monitoring and, systematically, evaluating the symptoms of these patients. This tool, validated for the Portuguese language, has been applied with the support of the nursing teams. In Nurses Focus Group model they discuss the main challenges in using the MPN-10 assessment tool, following which the present guide was developed. The most relevant aspects of the application of this tool were identified: 1) to take into account that it is a self-completion scale; 2) the tool aims to assess the impact of the symptom using numerical categories and 3) the healthcare professionals should not refer / induce the patient for comparison with previous evaluations. To facilitate the understanding of the MPN-10 and methodology of filling by the patient, additional information was developed on each of the symptoms for use by the health professional at the moment of information/clarification to the patient.
publishDate 2018
dc.date.none.fl_str_mv 2018-06-20
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://onco.news/index.php/journal/article/view/77
url https://onco.news/index.php/journal/article/view/77
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://onco.news/index.php/journal/article/view/77
https://onco.news/index.php/journal/article/view/77/93
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv AEOP – Associação de Enfermagem Oncológica Portuguesa
publisher.none.fl_str_mv AEOP – Associação de Enfermagem Oncológica Portuguesa
dc.source.none.fl_str_mv Onco.news; No. 36 (2018): Onco.News Journal (january-june); 41-44
Onco.News; N.º 36 (2018): Revista Onco.News (janeiro-junho); 41-44
2183-6914
1646-7868
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138187225858048